- Home
- CRI vs VRDN Comparison
CRI vs VRDN Comparison
Compare CRI & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRI
- VRDN
- Stock Information
- Founded
- CRI 1865
- VRDN 2006
- Country
- CRI United States
- VRDN United States
- Employees
- CRI N/A
- VRDN N/A
- Industry
- CRI Apparel
- VRDN Medical Specialities
- Sector
- CRI Consumer Discretionary
- VRDN Health Care
- Exchange
- CRI Nasdaq
- VRDN Nasdaq
- Market Cap
- CRI 1.5B
- VRDN 1.6B
- IPO Year
- CRI 2003
- VRDN N/A
- Fundamental
- Price
- CRI $37.47
- VRDN $11.61
- Analyst Decision
- CRI Hold
- VRDN Buy
- Analyst Count
- CRI 4
- VRDN 12
- Target Price
- CRI $49.00
- VRDN $36.44
- AVG Volume (30 Days)
- CRI 1.9M
- VRDN 781.0K
- Earning Date
- CRI 04-25-2025
- VRDN 05-07-2025
- Dividend Yield
- CRI 9.00%
- VRDN N/A
- EPS Growth
- CRI N/A
- VRDN N/A
- EPS
- CRI 5.12
- VRDN N/A
- Revenue
- CRI $2,844,102,000.00
- VRDN $302,000.00
- Revenue This Year
- CRI N/A
- VRDN N/A
- Revenue Next Year
- CRI $0.35
- VRDN $20,553.29
- P/E Ratio
- CRI $6.95
- VRDN N/A
- Revenue Growth
- CRI N/A
- VRDN N/A
- 52 Week Low
- CRI $35.16
- VRDN $11.40
- 52 Week High
- CRI $81.00
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- CRI 26.97
- VRDN 28.10
- Support Level
- CRI $39.95
- VRDN $14.03
- Resistance Level
- CRI $42.18
- VRDN $15.91
- Average True Range (ATR)
- CRI 1.63
- VRDN 0.70
- MACD
- CRI -0.21
- VRDN -0.24
- Stochastic Oscillator
- CRI 4.16
- VRDN 2.21
About CRI Carter's Inc.
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.